Dr. Levin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10970 Shadow Creek Pkwy
Ste 280
Pearland, TX 77584Phone+1 713-436-7500Fax+1 713-436-7503- Is this information wrong?
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2017
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2011 - 2013
- McGovern Medical School at UTHealthClass of 2011
- MD Anderson Cancer CenterPh.D., Cancer Biology, 2005 - 2010
- University of HoustonBS, Biology, Summa Cum Laude, Highest GPA in the College of Natural Sciences and Mathematics (Banner Bearer), 1999 - 2002
Certifications & Licensure
- TX State Medical License 2013 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer. Start of enrollment: 2016 Nov 01
Publications & Presentations
PubMed
- 14 citationsSpotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to datePavel A. Levin, Jonathan E. Dowell> ;Oncotargets and Therapy. 2017 Apr 7
- 32 citationsAxl Receptor Axis: A New Therapeutic Target in Lung CancerPavel A. Levin, Rolf A. Brekken, Lauren Averett Byers, John V. Heymach, David E. Gerber> ;Journal of Thoracic Oncology. 2016 Aug 1
- 51 citationsHistologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition.Pavel A. Levin, Melissa Mayer, Sharon Hoskin, Joseph L. Sailors, Dwight H Oliver, David E. Gerber> ;Journal of Thoracic Oncology. 2015 Sep 1
- Join now to see all
Press Mentions
- Texas Researchers Summarize Promising Research on New Mesothelioma Drug, According to Surviving MesotheliomaMay 2nd, 2017
Professional Memberships
- Member
- Member
- Member
Other Languages
- Russian
Hospital Affiliations
- Memorial Hermann Southeast HospitalHouston, Texas
- Memorial Hermann Physician NetworkHouston, Texas
- HCA Houston Healthcare Clear LakeLeague City, Texas
- Houston Methodist Clear Lake HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: